Recombinant Human CHMP2A Protein，His

CHMP2A (charged multivesicular body protein 2A) is an essential component of the endosomal sorting complexes required for transport (ESCRT) machinery, which plays a critical role in intracellular membrane trafficking, particularly in the formation and budding of multivesicular bodies (MVBs). The study of CHMP2A recombinantly expressed proteins has gained significant attention due to its implications in various cellular processes, including receptor downregulation, autophagy, and the inward budding of membrane proteins. Mutations or dysregulation in CHMP2A have been associated with several pathological conditions, including neurodegenerative diseases and certain cancers, indicating its potential as a therapeutic target. Recent advancements in recombinant protein technology have enabled the production of CHMP2A proteins, allowing researchers to investigate their structural properties, functional dynamics, and interactions with other ESCRT components. Understanding CHMP2A's role in cellular mechanisms not only enhances our knowledge of fundamental biological processes but also opens avenues for developing innovative strategies for disease intervention. As the field evolves, the characterization of CHMP2A reconstituted in vitro systems alongside advanced imaging techniques will further elucidate its contributions to cellular homeostasis and pathology, making it a focal point for future research in cell biology and therapeutic development.